Molecular markers associated with diseases can be visualized and quantified noninvasively with targeted ultrasound contrast agent (t-UCA) consisting of microbubbles (MBs) that can bind to specific molecular targets. Techniques used for quantifying t-UCA assume that all unbound MBs are taken out of the blood pool few minutes after injection and only MBs bound to the molecular markers remain. However, differences in physiology, diseases, and experimental conditions can increase the longevity of unbound MBs. In such conditions, unbound MBs will falsely be quantified as bound MBs. We have developed a novel technique to distinguish and classify bound from unbound MBs. In the post-processing steps, first, tissue motion was compensated using block...
In designing targeted contrast agent materials for imaging, the need to present a targeting ligand f...
Ultrasound imaging can be combined with specific targeted contrast agents for noninvasive detection ...
Cancer growth requires angiogenesis; imaging of angiogenesis holds thus great potential for improved...
Molecular markers associated with diseases can be visualized and quantified noninvasively with targe...
Molecular markers associated with diseases can be visualized and quantified noninvasively with targe...
Molecular imaging with ultrasound relies on microbubble contrast agents (MCAs) selectively adhering ...
The growing demand for a personalized approach to treatment of disease has accentuated the importanc...
Abstract Microbubbles (MB) are routinely used as contrast agents for functional and molecular ultras...
Contrast-enhanced ultrasound with targeted microbubble contrast agents is an emerging technique for ...
The link between cancer growth and angiogenesis has led to the development of new techniques for can...
Ultrasound molecular imaging is a powerful diagnostic modality employing microbubbles coated with ta...
In designing targeted contrast agent materials for imaging, the need to present a targeting ligand f...
Ultrasound imaging can be combined with specific targeted contrast agents for noninvasive detection ...
Cancer growth requires angiogenesis; imaging of angiogenesis holds thus great potential for improved...
Molecular markers associated with diseases can be visualized and quantified noninvasively with targe...
Molecular markers associated with diseases can be visualized and quantified noninvasively with targe...
Molecular imaging with ultrasound relies on microbubble contrast agents (MCAs) selectively adhering ...
The growing demand for a personalized approach to treatment of disease has accentuated the importanc...
Abstract Microbubbles (MB) are routinely used as contrast agents for functional and molecular ultras...
Contrast-enhanced ultrasound with targeted microbubble contrast agents is an emerging technique for ...
The link between cancer growth and angiogenesis has led to the development of new techniques for can...
Ultrasound molecular imaging is a powerful diagnostic modality employing microbubbles coated with ta...
In designing targeted contrast agent materials for imaging, the need to present a targeting ligand f...
Ultrasound imaging can be combined with specific targeted contrast agents for noninvasive detection ...
Cancer growth requires angiogenesis; imaging of angiogenesis holds thus great potential for improved...